Previous research indicates the involvement of FGFR1 in activating TBXT expression in lung cancer via MAPK signaling [16], while a super‐enhancer downstream of TBXT is evident in chordoma [17, 18]. This evidence concerns the gene FGFR1 and lung carcinoma.